Literature DB >> 10469019

Pituitary apoplexy following metastasis of bronchogenic adenocarcinoma to a prolactinoma.

F W Hanna1, O M Williams, J S Davies, T Dawson, J Neal, M F Scanlon.   

Abstract

A 42-year-old house wife presented with worsening headaches over 6 months in the absence of visual symptoms or symptoms suggestive of focal neurology. She was a life-long smoker. Systems review was unremarkable apart from secondary amenorrhoea and galactorrhoea of 6 months duration. Her serum prolactin was found to be 620 mU/l (60-400), FT4 12.6 nmol/l (9.8-23.1), TSH 1.38 mU/l (0.35-5.5), oestradiol < 73 pmol/l, LH and FSH of 4.4 and 12.6 mIU/l, respectively. She was on bromocriptine. A presumptive diagnosis of pneumonia, based on pyrexia and CXR findings, was made and she was started on IV antibiotics. Two days later she developed meningism and deterioration of conscious level. (Lumbar puncture results: no organisms, 312 neutrophils and 164 lymphocytes). CT scan revealed a 2.5-cm pituitary adenoma, with suprasellar extension. A repeat hormonal profile revealed FSH 1.4, LH < 0.3 mU/l, oestradiol < 73 pmol/l, prolactin 488 mU/l (60-400), and low random cortisol at 29 nmol/l. T1-weighted MRI revealed a large pituitary mass with evidence of haemorrhage. The patient subsequently underwent a transsphenoidal exploration with resection of the pituitary lesion. Whilst awaiting the histopathology results, CT of chest revealed a 1. 5-cm diameter rounded well defined density in the right lower lobe associated with hilar, pre- and right para-tracheal lymphadenopathy. The histopathology of the pituitary lesion, obtained piecemeal, revealed fragments of fibrous tissue infiltrated by sheets of acidophilic prolactin-positive cells, in keeping with a prolactinoma. In addition, other fragments with blood clot included highly atypical epithelial cells with mitotic figures. These were negative for prolactin but showed HMFG-and CEA-positivity, excluding them from a pituitary lineage. Transbronchial biopsy revealed moderately differentiated adenocarcinoma, with evidence of lymphatic spread. The overall conclusion was of bronchogenic adenocarcinoma, metastasizing to a prolactinoma and complicated by apoplexy.

Entities:  

Mesh:

Year:  1999        PMID: 10469019     DOI: 10.1046/j.1365-2265.1999.00717.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Diagnosis and management of isolated pituitary metastasis from adenocarcinoma of unknown origin presenting as loss of libido.

Authors:  Julien Feghaly; George Astras
Journal:  BMJ Case Rep       Date:  2015-03-31

2.  Pituitary apoplexy in a patient with suspected metastatic bronchogenic carcinoma.

Authors:  Bik Ling Man; Yat Pang Fu
Journal:  BMJ Case Rep       Date:  2014-06-02

Review 3.  Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review.

Authors:  Ribal Al-Aridi; Katia El Sibai; Pingfu Fu; Mehreen Khan; Warren R Selman; Baha M Arafah
Journal:  Pituitary       Date:  2014-12       Impact factor: 4.107

Review 4.  Twelve cases of pituitary metastasis: a case series and review of the literature.

Authors:  Mendel Castle-Kirszbaum; Tony Goldschlager; Benjamin Ho; Yi Yuen Wang; James King
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

5.  Pituitary Metastatic Composite Tumors: A Case Report with Next-Generation Sequencing and Review of the Literature.

Authors:  Matthew Helton; Muhammad Abu-Rmaileh; Kevin Thomas; Murat Gokden; Alissa Kanaan; Analiz Rodriguez
Journal:  Case Rep Oncol Med       Date:  2020-07-21

Review 6.  Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review.

Authors:  Umberto Goglia; Diego Ferone; Marilena Sidoti; Renato Spaziante; Patrizia Dadati; Jean-Luis Ravetti; Giuseppe Villa; Lisa Bodei; Giovanni Paganelli; Francesco Minuto; Massimo Giusti
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 7.  Best Practice No 172: pituitary gland pathology.

Authors:  J W Ironside
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

8.  Sellar and parasellar metastatic tumors.

Authors:  Tamer Altay; Khaled M Krisht; William T Couldwell
Journal:  Int J Surg Oncol       Date:  2011-10-13

9.  Pituitary sex hormones enhance the pro‑metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase‑1.

Authors:  Ahmed Abdelbaset-Ismail; Daniel Pedziwiatr; Gabriela Schneider; Jacek Niklinski; Radoslaw Charkiewicz; Marcin Moniuszko; Magda Kucia; Mariusz Z Ratajczak
Journal:  Int J Oncol       Date:  2016-12-02       Impact factor: 5.650

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.